Patients who suffered adverse gastrointestinal issues after taking Trulicity may qualify for compensation by taking legal action
The calcineurin-TFEB-p62 pathway mediates the activation of cardiac macroautophagy by proteasomal malfunction
Studies of microdosing found that people who microdose may notice steady energy, less cravings, and gradual weight loss without the side effects that sometimes come with larger doses
Bottom Line: If you feel you need a stronger medication, the answer is usually to switch to a different molecule under medical supervision, not to exceed the safety limits of your current one
2018;13:e0209336 Irizarry KJ, Malladi SB, Gao X, Mitsouras K, Melendez L, Burris PA, et al